Definitive Merger Agreement Reached Between NLS and Kadimastem
The companies will combine to focus on advancing NLS’ orexin platform and Kadimastem’s cell therapy program.
Tag: Mazindol
All
Latest
All
Latest
Mazindol Demonstrates Low Risk for Drug Interactions in Narcolepsy Treatment
Swiss clinical-stage biopharmaceutical company NLS Pharmaceutics Ltd announced positive data from five in vitro drug-drug interaction studies investigating mazindol.